U.S. market Closed. Opens in 1 day 5 hours 2 minutes

BMRN | BioMarin Pharmaceutical Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for BMRN we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is exceptionally good and Health is strong.

Valuation (55%)

Company Industry
P/E Ratio (TTM) 38.80 -15.27
PEG Ratio (TTM) 1.45 -4.35
P/S Ratio (TTM) 4.55 45.97
P/B Ratio (TTM) 2.31 28.96
P/FCF Ratio (TTM) 41.59 -2.59
Price to 5YR AVG Earnings Ratio 55.68 -5.56
Price to 5YR AVG FCF Ratio 548.73 -12.33

Profitability (30%)

Company Industry
ROA (TTM) 4.70% -19.06%
ROE (TTM) 6.22% 15.70%
Net Profit Margin (TTM) 11.72% -813.88%
ROIC 5YR AVG -0.13% 3.12%

Growth (93%)

4QTR AVG 3YR AVG 5YR AVG
EPS 75.15% 1,238.98% 810.24%
Revenue 6.29% 7.56% 10.33%
Net Income 76.37% 1,214.25% 796.42%
Cash Flow 57.63% 157.48% 84.15%

Health (61%)

Company Industry
Current Ratio (TTM) 4.27 5.56
Quick Ratio (TTM) 2.62 5.34
D/E Ratio (TTM) 0.11 0.95
Interest Coverage (TTM) 19.36 -6.44
Piotroski F-Score 5 5
Altman Z-Score 6.16 12.45
LTL to 5YR AVG FCF 26.01 0.11
Shares Outstanding Growth 5YR AVG 1.19% 37.46%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙